APL

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML), characterized by abnormal promyelocytes and a high risk of bleeding. It’s distinct from other AML types in that it’s highly curable with targeted therapies like all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), often without the need for chemotherapy.